Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study
Open Access
- 8 May 2023
- journal article
- research article
- Published by Elsevier in General Hospital Psychiatry
- Vol. 83, 185-193
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult FindingsPLOS ONE, 2013
- Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of LightFrontiers in Behavioral Neuroscience, 2011
- Cannabis use and cognition in schizophreniaFrontiers in Human Neuroscience, 2009
- Effects of cannabis use on outcomes of psychotic disorders: systematic reviewThe British Journal of Psychiatry, 2008
- Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteersInternational Journal of Neuropsychopharmacology, 2008
- Substance abuse and schizophrenia: Pharmacotherapeutic interventionJournal of Substance Abuse Treatment, 2008
- Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis UseTherapeutic Drug Monitoring, 2006
- Comparisons of Patients With Comorbid Psychiatric and Substance Use Disorders: Implications for Treatment and Service DeliveryAmerican Journal of Psychiatry, 2004
- Do hallucinogens cause residual neuropsychological toxicity?Drug and Alcohol Dependence, 1999
- Drug Dosage in the ElderlyDrugs & Aging, 1998